drugset / Press release
Material Information - PharmaEssentia Files for an Additional Indication of Besremi (Ropeginterferon alfa-2b) for the Treatment of Essential Thrombocythemia (ET) with TFDA
2025-09-05 · PharmaEssentia · original pharmaessentia.com ↗
Download Material Information - PharmaEssentia Files for an Additional Indication of Besremi (Ropeginterferon alfa-2b) for the Treatment of Essential Thrombocythemia (ET) with TFDA Previous Next
The release as fetched from its publisher. pharmaessentia.com ↗